This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Abbott, Sinocare debate distinctiveness of three-dimensional trademark at UK trial

By Abhishek Kumar ( October 29, 2024, 17:27 GMT | Insight) -- US medical device maker Abbott Diabetes told a London court that its three-dimensional trademark for the “FreeStyle Libre” glucose monitoring device is valid and infringed by Sinocare. In closing arguments, Sinocare said Abbott’s trademark was “hopelessly non-distinctive.” A UK judge reserved his judgment for a later date.US medical device maker Abbott Diabetes told the UK High Court in London today that the three-dimensional trademark it uses in connection with the wearable glucose monitoring device “FreeStyle Libre” is both valid and infringed by Chinese rival Sinocare....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections